Vaitkus Paul T
Cardiology, M/C 715, University of Illinois at Chicago, 840 S Wood St, Chicago, IL 60612, USA.
Eur J Med Res. 2004 Mar 30;9(3):131-4.
Venous thromboembolism accounts for a large number of preventable deaths. The majority of these events occur in medical patients, but medical thromboprophylaxis remains underutilised in this population. The purpose of this review is to examine the results of recent clinical trials of low molecular weight heparins in the prevention of venous thromboembolic disease in medical patients. The available data make a compelling case in favor of widespread use of low molecular weight heparin in medical patients.
静脉血栓栓塞导致大量可预防的死亡。这些事件大多发生在内科患者中，但内科患者的血栓预防措施仍未得到充分利用。本综述的目的是研究低分子量肝素预防内科患者静脉血栓栓塞性疾病的近期临床试验结果。现有数据有力地支持在内科患者中广泛使用低分子量肝素。
